Evidence map›Paper›PMID 42059565›Full record

ArticleJournal of pediatric hematology/oncology2026

Process Analysis of Time to Antibiotics in Pediatric Patients With Fever in Neutropenia During Chemotherapy for Cancer.

Christa Koenig, Claudia E Kuehni, Nicole Bodmer, Philipp Ka Agyeman, Marc Ansari, Nicolas X von der Weid, Roland A Ammann

Abstract read
In one paragraph

Article in Journal of pediatric hematology/oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Christa KoenigDepartments of Pediatrics, Pediatric Hematology and Oncology.ORCID 0000-0002-9965-5183
Claudia E KuehniInstitute of Social and Preventive Medicine.ORCID 0000-0001-8957-2002
Nicole BodmerPediatric Oncology, Kinderspital Zürich, University of Zürich, Zürich.ORCID 0009-0009-0497-8747
Philipp Ka AgyemanPediatrics, Inselspital, Bern University Hospital.ORCID 0000-0002-8339-5444
Marc AnsariWomen, Pediatric Hematology and Oncology, Child and Adolescent, University Hospital of Geneva.ORCID 0000-0002-9649-6498
Nicolas X von der WeidPediatric Hematology and Oncology, University Children's Hospital Basel, University of Basel, Basel.ORCID 0000-0002-9555-3817
Roland A AmmannFaculty of Medicine, University of Bern, Bern.ORCID 0000-0002-1902-2352

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For fever in neutropenia (FN) during chemotherapy timely start of antibiotics is recommended. We analyzed time to antibiotics (TTA) and sub-timespans between detection of fever and start of antibiotics in children undergoing chemotherapy for cancer with FN. Specifically, we aimed to assess where delays occur, which variables influence TTA, and whether the order of certain process steps affects TTA. We analyzed 349 FN episodes reported prospectively in 155 Swiss patients from April 2016 to August 2018. In outpatients, the median TTA from fever to the start of antibiotics was 165 minutes, and the median duration from fever to hospital arrival was 80 minutes. For inpatients, the median TTA from fever to the start of antibiotics was 75 minutes. The longest delays were identified for the timespans from phone call to arrival (median, 75 min) and from arrival to decision on treatment (60 min). Known blood counts at recognition of fever, decision to treat FN before arrival at the emergency department, and arrival during office hours contributed to shorter TTA. In conclusion, the time before arrival is relevant and should be considered when optimizing TTA and evaluating its influence on outcomes. Support for transportation, using time to arrive for preparations, and regular blood counts could reduce TTA.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsFeverNeoplasmsNeutropeniaTime-to-TreatmentAdolescentChildChild, PreschoolFemaleHumansInfantMaleProspective StudiesTime FactorsTreatment DelayAnti-Bacterial AgentsAntineoplastic Agentschildren with cancerfebrile neutropenianeutropeniapediatric oncologytime to antibiotics

Identifiers

PMID42059565
PMCPMC13281975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.